The RDH5 gene helps recycle vitamin A in the eye so the retina can rebuild the light sensing pigment needed for vision, especially in dim light. Your body relies on this gene to reset vision after you move from a bright room into the dark. If the gene does not work properly, people may have very slow dark adaptation and lifelong night blindness, often with small pale spots seen in the retina. This pattern is most often linked to fundus albipunctatus, an inherited form of night blindness.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or direct processes in the body. Some genes carry the code for proteins, which are the parts of cells that do much of the work. Other genes mainly regulate when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. To explore this topic in more detail, you can visit the LearnHub.
Overview
RDH5Gene function
What if the gene works
The RDH5 gene helps the eye recycle vitamin A so the retina can make a light sensing molecule. This supports clear vision in dim light and helps your eyes adjust in the dark.
Risk
What if the gene does not work
Variants in the RDH5 gene most often cause fundus albipunctatus, an inherited eye condition with delayed dark adaptation and night vision problems. Milder to more severe variants can influence when symptoms appear and whether retinal changes develop.
Treatment
What does that mean for your treatment
No established treatment or drug choice is currently based specifically on a pathogenic or loss-of-function variant in the RDH5 gene. RDH5 related eye disease is being studied with vitamin A related medicines, including 9 cis retinoids, but this remains investigational.
Conditions associated with RDH5
Gene function
What if the gene works
In the eye, the RDH5 gene works in a thin layer behind the retina that helps keep vision running smoothly. It helps the eye recycle a form of vitamin A needed for clear sight, especially in dim light. This steady recycling lets light sensing cells reset after exposure to light and get ready to respond again.
In retinal support cells, the RDH5 gene helps turn a recycled form of vitamin A into the light sensing form used by visual pigments. This gives rod and cone cells a key ingredient they need to respond to light.
After light exposure, your eyes need to rebuild visual pigment so light sensing cells can work again. The RDH5 gene supports this reset step in the eye’s normal light recycling process.
By helping restore the molecule that rods rely on, the RDH5 gene supports vision in dim light and at night. This same process helps your eyes adjust when you move from a bright place into a darker one.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, or the way the body responds to environmental influences. Many variants do not cause any noticeable effect and simply represent natural genetic variation. In some situations, though, a variant can change how a gene functions to a greater degree and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
To understand how variants in the RDH5 gene affect retinal cells, it helps to know that many changes make the enzyme unstable, poorly shaped, or absent, so vitamin A is recycled less efficiently. Milder variants may leave some activity, while more severe variants can greatly reduce it or stop it altogether. This range often helps explain why delayed dark adaptation and fundus albipunctatus can vary in when they begin and how noticeable they are.
How variants are linked to conditions
Pathogenic variants in the RDH5 gene cause fundus albipunctatus, a rare inherited eye condition that often leads to lifelong night blindness and very slow adjustment to darkness. This RDH5 gene and night blindness link is well established and usually shows up in childhood. Some people with variants in the RDH5 gene also develop later changes in central or color vision, although severity can vary.
A variant is not necessarily a diagnosis
Genetic variants are a routine part of human biology and are common across the general population. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when more than one gene and environmental factors play a role. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For RDH5, risk is mainly shaped by inherited gene changes rather than lifestyle. The chance of having an RDH5-related eye condition is higher when both biological parents carry a harmful RDH5 variant, especially in families with a history of the condition. There is not enough evidence to say that diet, supplements, or daily habits change the underlying genetic risk.
Inheritance of RDH5 variants
RDH5-related eye conditions are inherited in an autosomal recessive pattern. This means a person usually develops the condition only when they inherit two disease-causing variants in the RDH5 gene, one from each parent. Parents who each carry one variant are typically unaffected carriers. When both parents are carriers, each pregnancy has a 25% chance of an affected child, a 50% chance of a carrier child, and a 25% chance of a child with neither familial variant.
What does my RDH5 result mean for my family?
For families with an RDH5-related eye condition, the pattern is usually recessive, which means close relatives may be healthy carriers without knowing it. Brothers and sisters could also have the condition or be carriers, while parents are often carriers as well. For future children, the family impact depends on whether both parents carry an RDH5 change.
Genetic information
Genetic testing
How you find out about variants
RDH5 genetic testing looks for variants in the RDH5 gene using a blood sample, saliva sample, or cheek swab. A lab reads the gene’s DNA code, usually with sequencing, to check for changes linked to inherited retinal conditions. Results can show whether you carry one or two variants and whether testing helps confirm the diagnosis.
When should I consider getting a genetic test?
Consider RDH5 genetic testing if there is lifelong trouble seeing in dim light, very slow adjustment after moving from bright light to darkness, or a family history of an inherited night-vision condition. Testing can help confirm whether changes in the RDH5 gene are the cause.
A genetic result is only one part of your health story
A genetic result may provide useful insight, yet how much it can explain depends on the condition and on the kind of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. In some conditions, especially those shaped by many genes, genetic information offers context rather than certainty and is best considered along with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results may help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in genes can change how the body breaks down, transports, or responds to a drug, so the same treatment may work better for one person than another. This is a common part of normal human variation and can influence how much benefit someone gets or how sensitive they are to side effects. Other factors, including age, liver and kidney function, and other medicines, also play a role.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape medication response. It focuses on connections between genes and drugs to help explain why treatments can work differently from one person to another. For many medicines, genes influence either how strongly a drug works or how the body processes it. This information can support treatment decisions that are more informed and more individualized. You can explore this topic further in the LearnHub.
Drugs influenced by the RDH5 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so any concerns about side effects, new symptoms, or how your medicines may affect you are best discussed with your doctor.
History
RDH5 entered medical genetics in the 1990s, when researchers studying inherited night blindness linked variants in this gene to fundus albipunctatus, a rare retinal condition. Initially understood only through visible traits, later recognized as tied to a specific gene, this condition became one of the clearest examples of how gene discovery could explain a long described eye pattern. From these first observations, research expanded steadily. Scientists then identified additional RDH5 variants in families from different countries, which helped confirm the gene’s role and showed that the condition could appear across many populations. Over time, descriptions became more precise. These studies helped move care from symptom based labeling toward genetic confirmation and clearer family counseling.